6751 - 6760 of 9140 Results
Title
Year
-
OPENTitle: LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2536End Page: 2541Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23314Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2978749Citation Count: 70
- Increased Dynamics of α-Synuclein Fibrils by β-Synuclein Leads to Reduced Seeding and Cytotoxicity2019OPENTitle: Increased Dynamics of α-Synuclein Fibrils by β-Synuclein Leads to Reduced Seeding and CytotoxicityJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page: 17579End Page: 17579Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-019-54063-8Best OA location URL: https://www.nature.com/articles/s41598-019-54063-8.pdfCitation Count: 23
-
OPENTitle: Dopamine agonist treatment increases sensitivity to gamble outcomes in the hippocampus in de novo Parkinson’s diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 28Issue #:Start Page: 102362End Page: 102362Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nicl.2020.102362Best OA location URL: https://doi.org/10.1016/j.nicl.2020.102362Citation Count: 2
- Endogenous 2-oxoglutarate levels impact potencies of competitive HIF prolyl hydroxylase inhibitors2011RESTRICTEDTitle: Endogenous 2-oxoglutarate levels impact potencies of competitive HIF prolyl hydroxylase inhibitorsJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 64Issue #: 3Start Page: 268End Page: 273Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.phrs.2011.03.017Citation Count: 54
- The challenges of experimental pharmacology in identifying novel treatments for Parkinson's disease2026OPENTitle: The challenges of experimental pharmacology in identifying novel treatments for Parkinson's diseaseJournal Name: Current Opinion in NeurobiologyPublisher: Elsevier BVVol: 97Issue #:Start Page: 103164End Page: 103164Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.conb.2025.103164Best OA location URL: https://doi.org/10.1016/j.conb.2025.103164Citation Count: 2
-
OPENTitle: Non-MRI biomarkers should be accepted to guide treatment escalation in MS: YesJournal Name: Multiple Sclerosis JournalPublisher: SAGE PublicationsVol:Issue #:Start Page: 13524585261439622End Page: 13524585261439622Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1177/13524585261439622Best OA location URL: https://doi.org/10.1177/13524585261439622Citation Count: 0
-
OPENTitle: Chiral Dihydrobenzofuran Acids Show Potent Retinoid X Receptor–Nuclear Receptor Related 1 Protein Dimer ActivationJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 59Issue #: 3Start Page: 1232End Page: 1238Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.5b01702Best OA location URL: https://doi.org/10.7270/q2x63pt7Citation Count: 19
-
OPENTitle: Identification of small molecules that bind to the mitochondrial protein mitoNEETJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 26Issue #: 21Start Page: 5350End Page: 5353Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2016.09.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5482219Citation Count: 40
-
OPENTitle: Exploring variability in basal ganglia connectivity with functional MRI in healthy agingJournal Name: Brain Imaging and BehaviorPublisher: Springer Science and Business Media LLCVol: 12Issue #: 6Start Page: 1822End Page: 1827Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1007/s11682-018-9824-1Best OA location URL: https://link.springer.com/content/pdf/10.1007%2Fs11682-018-9824-1.pdfCitation Count: 26
- Free water is increased within the basal forebrain and suprachiasmatic pathways of isolated REM sleep behavior disorder2026RESTRICTEDTitle: Free water is increased within the basal forebrain and suprachiasmatic pathways of isolated REM sleep behavior disorderJournal Name: Sleep MedicinePublisher: Elsevier BVVol: 138Issue #:Start Page: 107859End Page: 107859Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.sleep.2025.107859Citation Count: 0